当前位置:首页 - 行情中心 - 科前生物(688526) - 财务分析 - 现金流量表

科前生物

(688526)

  

流通市值:57.99亿  总市值:57.99亿
流通股本:4.66亿   总股本:4.66亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金377,419,436.82219,745,519.68904,601,039.08743,014,382.13
  收到的税费返还---32,964.26
  收到其他与经营活动有关的现金16,724,534.263,566,776.7441,495,964.4526,891,146.76
  经营活动现金流入小计394,143,971.08223,312,296.42946,097,003.53769,938,493.15
  购买商品、接受劳务支付的现金16,909,664.5914,918,179.2183,684,820.36151,831,907.94
  支付给职工以及为职工支付的现金105,485,795.8571,660,010.93195,371,574.78155,781,523.47
  支付的各项税费76,318,231.6747,518,647.0191,770,563.9871,557,689.03
  支付其他与经营活动有关的现金79,573,832.5938,743,895.97106,728,211.1975,053,245.12
  经营活动现金流出小计278,287,524.7172,840,733.12477,555,170.31454,224,365.56
  经营活动产生的现金流量净额115,856,446.3850,471,563.3468,541,833.22315,714,127.59
二、投资活动产生的现金流量:
  收回投资收到的现金1,929,659,552.141,058,250,245.061,332,193,679.141,675,954,788.76
  取得投资收益收到的现金34,946,985.3213,615,479.2878,521,041.75110,440,942.56
  处置固定资产、无形资产和其他长期资产收回的现金净额--7,754,731.68-
  收到的其他与投资活动有关的现金11,196,528.17---
  投资活动现金流入小计1,975,803,065.631,071,865,724.341,418,469,452.571,786,395,731.32
  购建固定资产、无形资产和其他长期资产支付的现金35,573,069.9413,992,054.49123,878,027.0642,609,250.07
  投资支付的现金1,758,739,0001,085,990,0001,938,983,793.332,129,349,168.82
  取得子公司及其他营业单位支付的现金--4,500,0004,500,000
  支付其他与投资活动有关的现金4,662,411.03--8,559,185.33
  投资活动现金流出小计1,798,974,480.971,099,982,054.492,067,361,820.392,185,017,604.22
  投资活动产生的现金流量净额176,828,584.66-28,116,330.15-648,892,367.82-398,621,872.9
三、筹资活动产生的现金流量:
  吸收投资收到的现金---17,692,584
  收到其他与筹资活动有关的现金--17,692,584-
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--17,692,58417,692,584
  分配股利、利润或偿付利息支付的现金298,560,125.65-199,484,087.69199,543,845.81
  支付其他与筹资活动有关的现金967,287.26576,250.382,478,289.411,706,977.65
  筹资活动现金流出小计299,527,412.91576,250.38201,962,377.1201,250,823.46
  筹资活动产生的现金流量净额-299,527,412.91-576,250.38-184,269,793.1-183,558,239.46
四、汇率变动对现金及现金等价物的影响-15,970.82-9,243.55-2,056,879.58-47,468.47
五、现金及现金等价物净增加额-6,858,352.6921,769,739.22-366,677,207.28-266,513,453.24
  加:期初现金及现金等价物余额176,801,385.46176,801,385.46543,478,592.74543,478,592.74
  期末现金及现金等价物余额169,943,032.77198,571,124.68176,801,385.46276,965,139.5
补充资料:
  净利润114,723,822.66-416,941,266.13-
  资产减值准备8,642,244.07-12,636,565.86-
  固定资产和投资性房地产折旧60,038,188.45-107,523,702.65-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧60,038,188.45-107,523,702.65-
  无形资产摊销2,064,324.38-4,241,254.21-
  长期待摊费用摊销242,373.42-479,141.3-
  处置固定资产、无形资产和其他长期资产的损失1,895,027.12-6,896,508.3-
  固定资产报废损失--508,769.61-
  公允价值变动损失-18,336,038.27--33,271,389.35-
  财务费用-18,492,011.08--44,499,804.47-
  投资损失-4,523,727.69--7,405,727.22-
  递延所得税4,886,330.32-537,541.07-
  其中:递延所得税资产减少124,344.14-457,988.48-
    递延所得税负债增加4,761,986.18-79,552.59-
  存货的减少-14,942,008.76--30,953,325.53-
  经营性应收项目的减少18,014,511.46-54,547,824.63-
  经营性应付项目的增加-43,547,377.93--16,268,050.74-
  其他--4,831,281.82-
  融资租入固定资产--895,040.65-
  现金的期末余额169,943,032.77-176,801,385.46-
  减:现金的期初余额176,801,385.46-543,478,592.74-
  现金及现金等价物的净增加额-6,858,352.69--366,677,207.28-
公告日期2026-08-272026-04-302026-04-082025-10-30
审计意见(境内)标准无保留意见
TOP↑